Page last updated: 2024-08-23

ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Cardiomegaly

ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with Cardiomegaly in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bone, AJ; Koundakjian, PP; Rogers, MP; Sherratt, HS; Turnbull, DM; Younan, SI1

Other Studies

1 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Cardiomegaly

ArticleYear
Metabolic changes in fed rats caused by chronic administration of ethyl 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate, a new hypoglycaemic compound.
    Biochemical pharmacology, 1984, Feb-01, Volume: 33, Issue:3

    Topics: Animals; Body Weight; Carbohydrate Metabolism; Cardiomegaly; Dietary Fats; Epoxy Compounds; Ethers, Cyclic; Fatty Acids; Hypoglycemic Agents; Liver; Male; Microbodies; Muscles; Organ Size; Rats; Rats, Inbred Strains

1984